Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.16 USD | -0.02% | -12.44% | +2.26% |
May. 13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
May. 10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.26% | 1.5B | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.66% | 22.1B | |
-9.14% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Stifel Starts Soleno Therapeutics With Buy Rating, $63 Price Target